FIGS has seen its share price deliver a very strong run in recent years, which naturally puts the spotlight on whether the current valuation lines up with the cash the business can generate. With the stock now well above its levels of a few years ago, investors are increasingly asking how much of FIGS' cash flow story is already reflected in the price.
The issue now is whether FIGS' recent share price level is supported by the intrinsic value suggested by its cash flows.
If you want a broader watchlist while you assess whether FIGS’ recent cash flow story justifies its price, a focused screen of 34 high quality undervalued stocks can be a useful next step.
The Discounted Cash Flow (DCF) model here is based on the cash FIGS can return to shareholders over time. On the latest twelve month numbers, the business generated about $144.5 million of free cash flow, and the model assumes that this cash generation grows from current levels rather than shrinking.
Analyst projections used in the DCF suggest rising free cash flow into the early 2030s, with estimates extending out to 2036 and then tapering into a steadier phase. Because those cash flows, when discounted back, imply an intrinsic worth meaningfully above the current $22.05 share price, the stock is priced as if the market is taking a more cautious view of that cash story. The third quarter 2026 update, which showed higher net revenues and double digit net income and adjusted EBITDA margins, helps explain why the model builds in ongoing cash generation even though the share price has not fully closed that gap yet. Find out what FIGS could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives pick up where FIGS' valuation puzzle leaves off by explaining what kind of future in growth, profitability and earnings would need to occur for the shares to be worth materially more or less than today. These Narratives are available on the platform's Community page. Rather than stopping at a single DCF output or ratio, they outline the business story that number relies on so you can monitor over time whether that story still matches reality.
The FIGS debate splits between a premium brand story with more room to run and a concern that enthusiasm already prices in a lot of that promise.
Bull case: 21% undervalued
According to the bullish analyst Narrative on Simply Wall St, the optimistic view leans heavily on customer monetization and new channels.
"Widening wallet share per healthcare professional as FIGS converts more scrub buyers into full head to toe customers, with non scrubwear already approaching roughly one fifth of revenue…"
Discover why this Narrative puts FIGS at 21% undervalued.
Bear case: 53% overvalued
julio, a Simply Wall St Community investor who wrote the Narrative, focuses more on execution risk and how fragile premium positioning can be.
"Execution. FIGS is in a precarious position where it has experienced a monumental decline in share price following a weakness in performance…"
Explore why this Narrative puts FIGS at 53% overvalued.
Valuation only tells part of the story, and Simply Wall St’s broader checks have picked up potential pressure points around FIGS that investors may want to review closely before making a call. Take a closer look at 1 warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com